A safe, natural way to replenish skin proteoglycans

Zymbilan® tablets provide bioactive Proteoglycan Replacement Therapy for addressing psoriatic skin symptoms.

Vercilex®-F, the active ingredient in Zymbilan®-PRT, contains the specific proteoglycans involved in regulating Epidermal Dysglycania (EDG). It helps address psoriasis symptoms and other chronic skin disorders.

Combine Zymbilan®-PRT Tablets with Zymbilan®-PSO Cream for intra- and extra-cellular rebalancing therapy that delivers clinically proven results for alleviating psoriasis symptoms.

What is EDG?

 

Epidermal Dysglycania (EDG) occurs when skin proteoglycans decrease.

The resulting imbalance of proteoglycans under the surface of the skin triggers a faulty immune response, causing the body to accelerate skin cell production. Excessive skin cells are produced and then accumulate on the surface causing shedding, scaling, and plaque formation – all common symptoms of psoriasis.

 

 

Proteoglycan Replacement Therapy (PRT) for treating EDG

Zymbilan®-PRT tablets with Vercilex®-F contain a combination of skin specific, natural, marine proteoglycans that have been proven to address EDG by rebalancing the turnover of skin matrix components that are integral to cell growth and differentiation pathways.

The bioactive proteoglycans in Vercilex®-F also express broad anti-inflammatory properties which help alleviate the symptoms of psoriasis.

Zymbilan®-PRT tablets with Vercilex®-F work by:

  • Modulating the aberrant immune response and anti-inflammatory properties
  • Inhibiting the hyperproliferation of keratinocytes
  • Treating EDG by rebalancing the turnover of proteoglycans
  • Improving the function of epidermal stem cells

Vercilex®-F was developed by Pharma Medico in Scandinavia as a Proteoglycan Replacement Therapy (PRT) targeted specifically at skin disorders and it is backed by more than 30 years of research. It has been proven effective in addressing a number of inflammatory skin conditions, including:

  • Scalp psoriasis
  • Chronic plaque psoriasis
  • Inverse or flexural psoriasis
  • Pustular psoriasis
  • Guttate psoriasis

and other fungal infections and retinoid-sensitive disorders, like:

  • Dermatitis
  • Eczema
  • Pityriasis rosea

Zymbilan®-PRT tablets are safe and recognised by health authorities on all continents, including: The FDA, Anvisa, Cofepris, and EFSA (European Food Safety Authority).

 

Values Per 2 Tablets (daily serving)
Vercilex®-F 640 mg

Ingredient List (full)

Vercilex®-F (fractionated fish extract with specific lectican proteoglycans), bulking agents (microcrystalline cellulose; silicon dioxide), glazing agents (polyvinyl alcohol; polyethylene glycol), anti-caking agents (magnesium salts of fatty acids, talc), stabilizer (hydroxypropyl methyl cellulose), colour (calcium carbonate; iron oxides), zinc.

Precautions

  • Always read the label. Not recommended for those allergic to fish.
  • Zymbilan® dual topical and per oral therapy must not be used in patients with hypersensitivity to any of their ingredients.
  • No interactions between Zymbilan®-PRT tablets and other supplements and medications have been reported.

Directions
Take 2-4 tablets per day divided in two daily doses, one in the morning and one in the evening, preferably after food.

Treatment should continue until the skin lesions are resolved or as recommended by a healthcare professional. Long-term maintenance therapy to prevent rebound may be considered.